Post-effective amendment to a registration statement that is not immediately effective upon filing

Consolidated Statements of Changes in Stockholders' (Deficit)

v3.21.4
Consolidated Statements of Changes in Stockholders' (Deficit) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at the beginning of the period at Sep. 30, 2019 $ 172,612 $ 37,885,151 $ (38,865,060) $ (807,297)
Balance at the beginning of the period (in shares) at Sep. 30, 2019 172,612,233      
Net loss $ 0 0 (4,691,377) (4,691,377)
Issuance of common stock and warrants, net of financing costs $ 14,286 2,152,876 0 2,167,162
Issuance of common stock and warrants, net of financing costs (in shares) 14,285,714      
Shares issued for the exercise of stock options $ 5,182 927,546 0 932,728
Shares issued for the exercise of stock options (in shares) 5,181,819      
Issuance of restricted stock $ 965 (965) 0 0
Issuance of restricted stock (in shares) 965,000      
Stock based compensation expense $ 0 898,293 0 898,293
Balance at the ending of the period at Sep. 30, 2020 $ 193,045 41,862,901 (43,556,437) $ (1,500,491)
Balance at the ending of the period (in shares) at Sep. 30, 2020 193,044,766     193,044,766
Net loss $ 0   (6,240,482) $ (6,240,482)
Issuance of common stock and warrants, net of financing costs $ 43,125 6,176,108   6,219,233
Issuance of common stock and warrants, net of financing costs (in shares) 43,125,004      
Stock based compensation expense   496,066   496,066
Balance at the ending of the period at Sep. 30, 2021 $ 236,720 $ 48,534,525 $ (49,796,919) $ (1,025,674)
Balance at the ending of the period (in shares) at Sep. 30, 2021 236,719,770     236,719,770